Corium is a specialty pharmaceutical company focused on the development of advanced transdermal drug delivery technology. The company receives revenue from three partnered products (including Crest Whitestrips) and is now developing products internally. It has two platforms (Corplex and MicroCor) that enable the formulation of poorly soluble drugs and biologics respectively, both of which were previously intractable. There is the potential for four 505(b)2 approvals in 2019-21.
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Redefining the possibilities of drug patches
- Published:
19 May 2016 -
Author:
Maxim Jacobs -
Pages:
2
Corium is a specialty pharmaceutical company focused on the development of advanced transdermal drug delivery technology. The company receives revenue from three partnered products (including Crest Whitestrips) and is now developing products internally. It has two platforms (Corplex and MicroCor) that enable the formulation of poorly soluble drugs and biologics respectively, both of which were previously intractable. There is the potential for four 505(b)2 approvals in 2019-21.